Vergleich der Gastrinrezeptorszintigraphie mit der Positronenemissionstomographie, Computertomographie, Somatostatinrezeptorszintigraphie, Knochenmarks- und Knochenszintigraphie bei Patienten mit metastasierten medullären Schilddrüsenkarzinomen
Loading...
Files
Date
Authors
Publisher
Philipps-Universität Marburg
Abstract
Radiopeptide imaging is a valuable imaging method in the management of patients with neuroendocrine tumours (NET). To determine the clinical performance of gastrin receptor scintigraphy (GRS), it was compared with 18F-FDG positron emission tomography (PET), computed tomography (CT), somatostatin receptor scintigraphy (SRS), bone marrow- and bone scintigraphy in patients with metastasised/recurrent medullary thyroid carcinoma (MTC).
GRS had a higher tumour detection rate than SRS, PET and the other diagnostic methods in our study. GRS in combination with CT was most effective in the detection of metastatic MTC.
Review
Metadata
License
This item has been published with the following license: In Copyright